Mike Zablocki
General Manager
Mike is General Manager of the Malaghan Institute, responsible for the corporate, commercial and support functions of the organisation. He is also a Director of Wellington Zhaotai Therapies Limited, a joint venture established by the Malaghan Institute to develop innovative cell therapies for the global market.
Mike completed a Bachelor of Arts at the University of Bristol, before moving to New Zealand in 2002 when he joined the Malaghan as a database administrator. In 2011 he completed his Postgraduate Diploma in Business Administration at Victoria University of Wellington. He was appointed as General Manager in 2016.
Malaghan visiting researcher: Dr Lauren Holz
28 July 2026
Malaghan Institute to collaborate with IARC/WHO to reduce global burden of stomach cancer
24 July 2026
Reading a tumour’s fingerprint for personalised immunotherapies
22 July 2026
Farewell to Graham Malaghan, steward of a family legacy
6 July 2026
The changing face of allergy treatment
24 June 2026
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026
Malaghan visiting researcher: Dr Lauren Holz
28 July 2026
Malaghan Institute to collaborate with IARC/WHO to reduce global burden of stomach cancer
24 July 2026
Reading a tumour’s fingerprint for personalised immunotherapies
22 July 2026
Farewell to Graham Malaghan, steward of a family legacy
6 July 2026
The changing face of allergy treatment
24 June 2026
Breakthrough Malaghan and University of Auckland cancer research advances into new biotech venture
16 June 2026